_________
false
C002
אקס טי אל ביופרמסוטיקלס בע"מ
2
Public
X T L BIOPHARMACEUTICALS LTD
4313
Corporation no:
520039470
Stock Exchange/Market:
NASDAQ CM
1996
380
HaCharoshet st
5
,
Ra'anana
43656
,
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E.mail address:
ir@xtlbio.com
Reported via MAGNA:
02/03/2016
Time of broadcast:
16:03
15:50:40
Company site:
www.xtlbio.com
Reference:
2016-02-039157
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
receiving a patent from the Hungarian Intellectual Property Office titled “Synthetic Human Peptides and Pharmaceutical Compositions Comprising Them for the Treatment of Systemic Lupus Erythematosus,” for hCDR1 in the treatment of lupus.
02_03_16_XTLB_6K_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
31/01/2016
Name of the Signatory:
:
Kntor Ronen
,
Position of Signatory in the reporting corporation:
Legal Adviser
,
Name of Employer Company:
.
Abba Hillel Silver Rd
12
Ramat Gan
5250606
Telephone:
03-6133371
,
Facsimile:
03-6133372
,
E-mail:
rkantor@kantor-law.com
2